Flavoring Agent · CAS 109-52-4

Valeric Acid

FDA status: Approved. EU: not separately listed. No U.S. state has enacted a specific ban yet.

Low Risk
Score 4 of 5
Valeric Acid: 4/5 (Low Risk)

According to the U.S. Food and Drug Administration, Valeric Acid is FDA-approved, and no U.S. state has moved to restrict it independently of federal policy.

Browse all Flavoring Agent additives →

The verdict

Valeric Acid is FDA-approved, and no U.S. state has moved to restrict it.

4/5
Low Risk
Approved
FDA status
-
EU status
0
state regulations

Valeric Acid: the CAS-identified regulatory record

Valeric Acid: no OFF product match; CAS 109-52-4 is the lead registry handle on this row.

Property Value Source
CAS Number 109-52-4 CAS Registry
FDA Status Approved FDA SAFFA
EU Status Not separately listed EC 1333/2008
E-Number - EU additive register
Category Flavoring Agent FDA functional class
Composite Safety Score 4 / 5 (Low Risk) PlainIngredients methodology
EFSA ADI Not in our EFSA data EFSA scientific opinion
U.S. State Actions 0 states State legislative records
Tracked Products Not yet tracked Open Food Facts (US)

Values reflect official agency classifications as published by the U.S. Food and Drug Administration and the European Union's regulatory framework. See our methodology for scoring details.

Valeric Acid, explained

Valeric Acid (CAS 109-52-4) is an FDA-regulated food substance used as flavoring agent or adjuvant.

Common Uses

flavoring agent or adjuvant

Catalog-profile peer axes

Valeric Acid among its nationwide catalog-profile peers

Product-count (0) and safety-score (4/5) peer columns, disjoint link sets.

Score 4/5 peers (≥50 OFF products)

Nearest other additives by PlainIngredients safety score (floored at ≥50 tracked products), distinct from the count row.

8 peers

Frequently Asked Questions

Is Valeric Acid safe to consume?

Valeric Acid scores 4/5 (Low Risk). FDA status is Approved. No OFF product match yet; the distinctive registry handle is CAS 109-52-4, so this page leads with the chemical identity row rather than a shelf-prevalence claim.